Home/Filings/4/0001493152-20-019255
4//SEC Filing

Patel Kinnary 4

Accession 0001493152-20-019255

CIK 0001799788other

Filed

Oct 8, 8:00 PM ET

Accepted

Oct 9, 6:02 PM ET

Size

19.6 KB

Accession

0001493152-20-019255

Insider Transaction Report

Form 4
Period: 2020-09-29
Patel Kinnary
10% Owner
Transactions
  • Exercise/Conversion

    Series B Preferred Stock

    2020-09-2976,7800 total(indirect: see footnote)
    Common Stock (76,780 underlying)
  • Exercise/Conversion

    Series D Preferred Stock

    2020-09-2945,3280 total(indirect: see footnote)
    Common Stock (45,328 underlying)
  • Exercise/Conversion

    Common Stock

    2020-09-29+76,78076,780 total(indirect: see footnote)
  • Exercise/Conversion

    Common Stock

    2020-09-29+52,620129,400 total(indirect: see footnote)
  • Other

    Series D Preferred Stock

    2020-09-29+7,2927,292 total(indirect: see footnote)
    Common Stock (7,292 underlying)
  • Exercise/Conversion

    Series D Preferred Stock

    2020-09-297,2920 total(indirect: see footnote)
    Common Stock (7,292 underlying)
Holdings
  • Common Stock

    (indirect: see footnote)
    2,405,670
  • Common Stock

    (indirect: see footnote)
    1,329,590
  • Common Stock

    (indirect: see footnote)
    1,320,226
Footnotes (8)
  • [F1]Kinnary Patel is the Trustee of the Kinnary Patel IRA and in such capacity has the right to vote and dispose of the securities held by such IRA.
  • [F2]The securities are owned by Patel Family Trust 1. Kinnary Patel, as co-Trustee of Patel Family Trust 1, shares voting and dispositive power over the securities held by such trust with her spouse.
  • [F3]The securities are owned by Patel Family Trust 2. Kinnary Patel, as co-Trustee of Patel Family Trust 2, shares voting and dispositive power over the securities held by such trust with her spouse.
  • [F4]The securities are owned by Patel Family Trust 3. Kinnary Patel, as co-Trustee of Patel Family Trust 3, shares voting and dispositive power over the securities held by such trust with her spouse.
  • [F5]The Series B Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
  • [F6]The Series D Preferred Stock converted into Issuer common stock on a 1-for-1 basis and had no expiration date.
  • [F7]The Series D Preferred Stock have no expiration date and are convertible, at the option of the holder, into shares of common stock of the Issuer at the then-effective conversion rate for no additional consideration (subject to the payment of cash, if applicable, in lieu of any fractional shares in accordance with the Issuer's Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation").
  • [F8]The Reporting Person was issued additional shares of Series D Preferred Stock in connection with the Issuer's initial public offering as a result of the anti-dilution protection provisions set forth in the Issuer's Certificate of Incorporation.

Documents

1 file

Issuer

Greenwich LifeSciences, Inc.

CIK 0001799788

Entity typeother

Related Parties

1
  • filerCIK 0001828008

Filing Metadata

Form type
4
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 6:02 PM ET
Size
19.6 KB